Susquehanna International Group
XBI icon

Susquehanna International Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Susquehanna International Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$432M Sell
3,382,400
-3,362,900
-50% -$420M 0.05% 303
2025
Q4 		$822M Buy
6,745,300
+1,132,700
+20% +$130M 0.09% 163
2025
Q3 		$562M Buy
5,612,600
+2,335,900
+71% +$210M 0.06% 237
2025
Q2 		$272M Buy
3,276,700
+275,800
+9% +$22M 0.04% 366
2025
Q1 		$243M Sell
3,000,900
-158,600
-5% -$14.2M 0.04% 336
2024
Q4 		$285M Buy
3,159,500
+189,700
+6% +$18.4M 0.04% 327
2024
Q3 		$293M Buy
2,969,800
+852,700
+40% +$83.8M 0.05% 292
2024
Q2 		$196M Sell
2,117,100
-3,743,700
-64% -$336M 0.04% 362
2024
Q1 		$556M Buy
5,860,800
+1,902,100
+48% +$177M 0.1% 157
2023
Q4 		$353M Buy
3,958,700
+1,595,300
+68% +$118M 0.07% 238
2023
Q3 		$173M Sell
2,363,400
-956,300
-29% -$76.4M 0.04% 397
2023
Q2 		$276M Sell
3,319,700
-921,400
-22% -$77.1M 0.06% 257
2023
Q1 		$323M Buy
4,241,100
+262,200
+7% +$21.8M 0.07% 235
2022
Q4 		$330M Sell
3,978,900
-1,116,900
-22% -$90.4M 0.08% 209
2022
Q3 		$404M Buy
5,095,800
+631,400
+14% +$53.2M 0.1% 149
2022
Q2 		$334M Sell
4,464,400
-1,288,600
-22% -$96.7M 0.08% 178
2022
Q1 		$522M Buy
5,753,000
+1,908,200
+50% +$176M 0.09% 155
2021
Q4 		$435M Sell
3,844,800
-1,359,200
-26% -$164M 0.07% 240
2021
Q3 		$654M Buy
5,204,000
+906,400
+21% +$117M 0.09% 169
2021
Q2 		$583M Sell
4,297,600
-220,900
-5% -$29M 0.08% 197
2021
Q1 		$613M Sell
4,518,500
-448,700
-9% -$67.2M 0.1% 160
2020
Q4 		$716M Buy
4,967,200
+59,700
+1% +$7.65M 0.12% 117
2020
Q3 		$548M Sell
4,907,500
-1,654,000
-25% -$185M 0.11% 134
2020
Q2 		$735M Buy
6,561,500
+1,108,500
+20% +$109M 0.18% 73
2020
Q1 		$425M Sell
5,453,000
-594,100
-10% -$52.6M 0.14% 118
2019
Q4 		$575M Buy
6,047,100
+1,810,200
+43% +$157M 0.17% 95
2019
Q3 		$324M Buy
4,236,900
+928,300
+28% +$77.1M 0.11% 152
2019
Q2 		$290M Buy
3,308,600
+82,000
+3% +$6.99M 0.11% 154
2019
Q1 		$292M Sell
3,226,600
-746,900
-19% -$63.5M 0.12% 136
2018
Q4 		$285M Buy
3,973,500
+1,645,700
+71% +$133M 0.11% 149
2018
Q3 		$223M Buy
2,327,800
+136,600
+6% +$13.2M 0.07% 224
2018
Q2 		$209M Buy
2,191,200
+757,700
+53% +$69.6M 0.07% 237
2018
Q1 		$126M Buy
1,433,500
+144,000
+11% +$13.1M 0.04% 326
2017
Q4 		$109M Sell
1,289,500
-208,500
-14% -$17.5M 0.04% 392
2017
Q3 		$130M Buy
1,498,000
+100,200
+7% +$8.03M 0.05% 309
2017
Q2 		$108M Buy
1,397,800
+374,800
+37% +$26.6M 0.05% 331
2017
Q1 		$70.9M Sell
1,023,000
-1,039,000
-50% -$69.8M 0.04% 432
2016
Q4 		$122M Buy
2,062,000
+794,800
+63% +$49.1M 0.06% 272
2016
Q3 		$84M Sell
1,267,200
-289,900
-19% -$17.9M 0.04% 362
2016
Q2 		$84.2M Sell
1,557,100
-620,400
-28% -$34M 0.05% 350
2016
Q1 		$112M Sell
2,177,500
-109,000
-5% -$5.66M 0.06% 278
2015
Q4 		$160M Sell
2,286,500
-1,557,000
-41% -$106M 0.07% 227
2015
Q3 		$239M Buy
3,843,500
+828,500
+27% +$65.3M 0.1% 166
2015
Q2 		$254M Buy
3,015,000
+1,371,600
+83% +$107M 0.11% 150
2015
Q1 		$124M Buy
1,643,400
+305,100
+23% +$21.3M 0.06% 305
2014
Q4 		$83.3M Buy
1,338,300
+464,400
+53% +$26.5M 0.03% 481
2014
Q3 		$45.4M Buy
873,900
+590,700
+209% +$30.1M 0.02% 801
2014
Q2 		$14.5M Sell
283,200
-1,085,700
-79% -$49M 0.01% 1700
2014
Q1 		$65M Buy
1,368,900
+1,217,700
+805% +$62.3M 0.03% 504
2013
Q4 		$6.56M Buy
151,200
+118,200
+358% +$4.89M ﹤0.01% 2564
2013
Q3 		$1.42M Sell
33,000
-478,200
-94% -$19.4M ﹤0.01% 4701
2013
Q2 		$17.8M Buy
+511,200
New +$18M 0.01% 1221

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's XBI Position: Q1 2026 in Review

Susquehanna International Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 80% in Q1 2026, selling an estimated $36.7M and leaving 74,189 shares worth $9.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

Susquehanna International Group first reported a position in XBI in Q2 2013 and has held it in 50 quarters since. The position peaked at $284M in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Susquehanna International Group held 74,189 shares of State Street SPDR S&P Biotech ETF worth $9.48M as of Q1 2026.
  • Susquehanna International Group sold 293,721 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $36.7M.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3193 holding.
  • Susquehanna International Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's State Street SPDR S&P Biotech ETF position peaked at $284M in Q4 2020.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.